My Quote Request
No products added yet
6505-01-533-5978
20 Products
NDC11509-0205-18
MENTHOL CETYLPYRIDI
NSN, MFG P/N
6505015335978
NSN
6505-01-533-5978
MFG
COMBE INCORPORATED
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 521600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MENTHOL CETYLPYRIDINIUM THROAT LOZENGES 18S
SPECIAL FEATURES: FOR SORE THROAT; LOZENGES INDIVIDUALLY SEALED BLISTER PACK, 3 STRIPS OF 6
Related Searches:
NDC49281-0790-51
TYPHOID VI POLYSACC
NSN, MFG P/N
6505015334962
NSN
6505-01-533-4962
MFG
SANOFI PASTEUR INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TYPHOID VI POLYSACCHARIDE VACCINE 0.5ML SINGLE DOSE PRESERVATIVE FREE
III SUPPLEMENTARY FEATURES: SINGLE DOSE;PRESERVATIVE FREE
SPECIAL FEATURES: EACH 0.5ML IS FORMULATED TO CONTAIN 25 UG OF PURIFIED VI POLYSACCHARIDE; 0.5ML LUER LOCK SYRINGE (WITHOUT NEEDLE); INTERMUSCULAR OR SUBCUTAENOUS ADMINISTRATION; STORE BETWEEN 2 AND 8 DEG C; DO NOT FREEZE; FOR PREVENTION OF TYPHOID FEVER IN ADULTS AND
~1: CHILDREN OVER 2 YEARS OF AGE; AHFS:80:12.00
Related Searches:
TYPHIM VI
TYPHOID VI POLYSACC
NSN, MFG P/N
6505015334962
NSN
6505-01-533-4962
MFG
SANOFI PASTEUR INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TYPHOID VI POLYSACCHARIDE VACCINE 0.5ML SINGLE DOSE PRESERVATIVE FREE
III SUPPLEMENTARY FEATURES: SINGLE DOSE;PRESERVATIVE FREE
SPECIAL FEATURES: EACH 0.5ML IS FORMULATED TO CONTAIN 25 UG OF PURIFIED VI POLYSACCHARIDE; 0.5ML LUER LOCK SYRINGE (WITHOUT NEEDLE); INTERMUSCULAR OR SUBCUTAENOUS ADMINISTRATION; STORE BETWEEN 2 AND 8 DEG C; DO NOT FREEZE; FOR PREVENTION OF TYPHOID FEVER IN ADULTS AND
~1: CHILDREN OVER 2 YEARS OF AGE; AHFS:80:12.00
Related Searches:
05-1555
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335252
NSN
6505-01-533-5252
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.025MG/24 HOUR PATCH 8/BOX 24S
OVERALL STRENGTH IN SYSTEM: 0.39MG ESTRADIOL USP ACTIVE INGREDIENT
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
SYSTEM SIZE: 2.5 SQUARE CENTIMETERS
USAGE DESIGN: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS
USUAL DOSE: 0.025MG RELEASE PER 24 HOURS
Related Searches:
NDC00078-0365-45
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335252
NSN
6505-01-533-5252
NDC00078-0365-45
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335252
NSN
6505-01-533-5252
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.025MG/24 HOUR PATCH 8/BOX 24S
OVERALL STRENGTH IN SYSTEM: 0.39MG ESTRADIOL USP ACTIVE INGREDIENT
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
SYSTEM SIZE: 2.5 SQUARE CENTIMETERS
USAGE DESIGN: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS
USUAL DOSE: 0.025MG RELEASE PER 24 HOURS
Related Searches:
VIVELLE-DOT
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335252
NSN
6505-01-533-5252
VIVELLE-DOT
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335252
NSN
6505-01-533-5252
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.025MG/24 HOUR PATCH 8/BOX 24S
OVERALL STRENGTH IN SYSTEM: 0.39MG ESTRADIOL USP ACTIVE INGREDIENT
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
SYSTEM SIZE: 2.5 SQUARE CENTIMETERS
USAGE DESIGN: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS
USUAL DOSE: 0.025MG RELEASE PER 24 HOURS
Related Searches:
05-1554
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335267
NSN
6505-01-533-5267
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.0375MG/24 HOURS PATCH 8EA 3S
OVERALL STRENGTH IN SYSTEM: 0.585MG ESTRADIOL USP ACTIVE INGREDIENT
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM
SYSTEM SIZE: 3.75 SQUARE CENTIMETERS
USUAL DOSE: 0.0375MG RELEASE PER 24 HOURS
~1: THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
Related Searches:
NDC00078-0343-45
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335267
NSN
6505-01-533-5267
NDC00078-0343-45
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335267
NSN
6505-01-533-5267
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.0375MG/24 HOURS PATCH 8EA 3S
OVERALL STRENGTH IN SYSTEM: 0.585MG ESTRADIOL USP ACTIVE INGREDIENT
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM
SYSTEM SIZE: 3.75 SQUARE CENTIMETERS
USUAL DOSE: 0.0375MG RELEASE PER 24 HOURS
~1: THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
Related Searches:
VIVELLE-DOT
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335267
NSN
6505-01-533-5267
VIVELLE-DOT
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335267
NSN
6505-01-533-5267
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.0375MG/24 HOURS PATCH 8EA 3S
OVERALL STRENGTH IN SYSTEM: 0.585MG ESTRADIOL USP ACTIVE INGREDIENT
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM
SYSTEM SIZE: 3.75 SQUARE CENTIMETERS
USUAL DOSE: 0.0375MG RELEASE PER 24 HOURS
~1: THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
Related Searches:
05-1553
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335291
NSN
6505-01-533-5291
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.05MG/24 HOURS PATCH 8EA 3S
OVERALL STRENGTH IN SYSTEM: 0.78MG ESTRADIOL USP ACTIVE INGREDIENT
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM
SYSTEM SIZE: 5.0 SQUARE CENTIMETERS
USUAL DOSE: 0.05MG RELEASE PER 24 HOURS
~1: THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
Related Searches:
NDC00078-0344-45
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335291
NSN
6505-01-533-5291
NDC00078-0344-45
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335291
NSN
6505-01-533-5291
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.05MG/24 HOURS PATCH 8EA 3S
OVERALL STRENGTH IN SYSTEM: 0.78MG ESTRADIOL USP ACTIVE INGREDIENT
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM
SYSTEM SIZE: 5.0 SQUARE CENTIMETERS
USUAL DOSE: 0.05MG RELEASE PER 24 HOURS
~1: THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
Related Searches:
VIVELLE-DOT
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335291
NSN
6505-01-533-5291
VIVELLE-DOT
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335291
NSN
6505-01-533-5291
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.05MG/24 HOURS PATCH 8EA 3S
OVERALL STRENGTH IN SYSTEM: 0.78MG ESTRADIOL USP ACTIVE INGREDIENT
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM
SYSTEM SIZE: 5.0 SQUARE CENTIMETERS
USUAL DOSE: 0.05MG RELEASE PER 24 HOURS
~1: THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
Related Searches:
05-1552
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335293
NSN
6505-01-533-5293
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.075MG/24 HOURS PATCH 8EA 3S
OVERALL STRENGTH IN SYSTEM: 1.17MG ESTRADIOL USP ACTIVE INGREDIENT
SPECIAL FEATURES: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM
SYSTEM SIZE: 7.5 SQUARE CENTIMETERS
USUAL DOSE: 0.075MG RELEASE PER 24 HOURS
~1: THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
Related Searches:
NDC00078-0345-45
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335293
NSN
6505-01-533-5293
NDC00078-0345-45
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335293
NSN
6505-01-533-5293
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.075MG/24 HOURS PATCH 8EA 3S
OVERALL STRENGTH IN SYSTEM: 1.17MG ESTRADIOL USP ACTIVE INGREDIENT
SPECIAL FEATURES: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM
SYSTEM SIZE: 7.5 SQUARE CENTIMETERS
USUAL DOSE: 0.075MG RELEASE PER 24 HOURS
~1: THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
Related Searches:
VIVELLE-DOT
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335293
NSN
6505-01-533-5293
VIVELLE-DOT
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335293
NSN
6505-01-533-5293
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.075MG/24 HOURS PATCH 8EA 3S
OVERALL STRENGTH IN SYSTEM: 1.17MG ESTRADIOL USP ACTIVE INGREDIENT
SPECIAL FEATURES: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM
SYSTEM SIZE: 7.5 SQUARE CENTIMETERS
USUAL DOSE: 0.075MG RELEASE PER 24 HOURS
~1: THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
Related Searches:
05-1551
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335301
NSN
6505-01-533-5301
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.1MG/24 HOURS PATCH 8EA 3S
OVERALL STRENGTH IN SYSTEM: 1.56MG ESTRADIOL USP ACTIVE INGREDIENT
SPECIAL FEATURES: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM
SYSTEM SIZE: 10.0 SQUARE CENTIMETERS
USUAL DOSE: 0.1MG RELEASE PER 24 HOURS
~1: THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
Related Searches:
NDC00078-0346-45
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335301
NSN
6505-01-533-5301
NDC00078-0346-45
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335301
NSN
6505-01-533-5301
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.1MG/24 HOURS PATCH 8EA 3S
OVERALL STRENGTH IN SYSTEM: 1.56MG ESTRADIOL USP ACTIVE INGREDIENT
SPECIAL FEATURES: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM
SYSTEM SIZE: 10.0 SQUARE CENTIMETERS
USUAL DOSE: 0.1MG RELEASE PER 24 HOURS
~1: THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
Related Searches:
VIVELLE-DOT
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335301
NSN
6505-01-533-5301
VIVELLE-DOT
ESTRADIOL TRANSDERMAL SYSTEM
NSN, MFG P/N
6505015335301
NSN
6505-01-533-5301
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 681604
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL TRANSDERMAL SYSTEM 0.1MG/24 HOURS PATCH 8EA 3S
OVERALL STRENGTH IN SYSTEM: 1.56MG ESTRADIOL USP ACTIVE INGREDIENT
SPECIAL FEATURES: USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM
SYSTEM SIZE: 10.0 SQUARE CENTIMETERS
USUAL DOSE: 0.1MG RELEASE PER 24 HOURS
~1: THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C
Related Searches:
05-1640
MENTHOL CETYLPYRIDI
NSN, MFG P/N
6505015335978
NSN
6505-01-533-5978
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 521600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MENTHOL CETYLPYRIDINIUM THROAT LOZENGES 18S
SPECIAL FEATURES: FOR SORE THROAT; LOZENGES INDIVIDUALLY SEALED BLISTER PACK, 3 STRIPS OF 6
Related Searches:
CEPACOL LOZENGES
MENTHOL CETYLPYRIDI
NSN, MFG P/N
6505015335978
NSN
6505-01-533-5978
MFG
COMBE INCORPORATED
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 521600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MENTHOL CETYLPYRIDINIUM THROAT LOZENGES 18S
SPECIAL FEATURES: FOR SORE THROAT; LOZENGES INDIVIDUALLY SEALED BLISTER PACK, 3 STRIPS OF 6
